$74.80
0.991.34%
After Hours: 9:10 AM EDT
Comments
Loading...
Insmed (NASDAQ:INSM) Stock Quotes, Forecast and News Summary
Insmed Stock (NASDAQ: INSM) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Insmed (INSM) stock?
You can purchase shares of Insmed (NASDAQ:INSM) through any online brokerage.
Who are Insmed (INSM) competitors?
Other companies in Insmed’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).
What is the forecast, or price target, for Insmed (INSM) stock?
Insmed has a consensus price target of $78.00.
What is the current price for Insmed (INSM)?
The stock price for Insmed (NASDAQ: INSM) is $73.31 last updated November 22, 2024 at 3:56 PM EST.
Does Insmed (INSM) pay a dividend?
There are no upcoming dividends for Insmed.
When is Insmed (NASDAQ:INSM) reporting earnings?
Insmed’s Q4 earnings are confirmed for Thursday, February 20, 2025.
Is Insmed (INSM) going to split?
There is no upcoming split for Insmed.
What sector and industry does Insmed (INSM) operate in?
Insmed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.